Innate Response Activator (IRA) B Cells Reside in Human Tonsils and Internalize Bacteria In Vitro
Innate response activator (IRA) B cells have been described in mice as a subset of B-1a B cells that produce granulocyte/macrophage colony-stimulating factor (GM-CSF) and have been found in the spleen upon activation. In humans, identification, tissue localization and functionality of these lymphocy...
Saved in:
Published in | PloS one Vol. 10; no. 6; p. e0129879 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
12.06.2015
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Innate response activator (IRA) B cells have been described in mice as a subset of B-1a B cells that produce granulocyte/macrophage colony-stimulating factor (GM-CSF) and have been found in the spleen upon activation. In humans, identification, tissue localization and functionality of these lymphocytes are poorly understood. We hypothesized that IRA B cells could reside in human palatine tonsils, which are a first line of defense from infection of the upper respiratory tract. In the present work, we used flow cytometry and confocal microscopy to identify and characterize human IRA (hIRA) B cells in tonsils. We show that CD19⁺CD20⁺GM-CSF⁺ B cells are present in the tonsils of all the subjects studied at a frequency ranging between ~0.2% and ~0.4% of the conventional CD19⁺CD20⁺GM-CSF⁻ B cells. These cells reside within the B cell follicles, are mostly IgM⁺IgD⁺, express CD5 and show phagocytic activity. Our results support a role for hIRA B cells in the effector immune response to infections in tonsils. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: NC, RC, LP, PR, DR, AM, SB, FC, and GDG are or were full time employees of Novartis Vaccines (a GSK company). AR and FM have no conflicts of interests to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Current address: Center for Human Immunology, NHLBI, NIH, Rockville Pike, Bethesda, Maryland, United States of America Conceived and designed the experiments: NC RC FC. Performed the experiments: NC RC. Analyzed the data: NC RC. Contributed reagents/materials/analysis tools: PR DR LP AM FM AR. Wrote the paper: NC. Scientific support and data discussion: SB GDG FC. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0129879 |